Join the tens of thousands who choose Curaleaf Clinic — Register today!

  • Home
  • News
  • New research published in December from the UK Medical Cannabis Registry

New research published in December from the UK Medical Cannabis Registry

At Sapphire Clinics, one of our founding principles is to ensure that we are adding to the research base that is available on medical cannabis, one of the key barriers to NHS access.

We are happy to share 4 new condition-specific research publications with you from the UK Medical Cannabis Registry that our researchers at Sapphire have been working hard on.

Those enrolled on the UK Medical Cannabis Registry have helped us with the following pieces of research: Post-Traumatic Stress Disorder, Inflammatory Bowel Disease, Depression and Children with Treatment-Resistant Epilepsy.

The aim of the UK Medical Cannabis Registry is to expand our understanding of medical cannabis in the UK by collecting and analysing clinical data. The Registry ensures that medical cannabis prescribing is evaluated in a responsible way, capturing essential data including prescribed formulations, adverse events, and patient-reported outcome measures. Data is collected from patients who consent via the Curaleaf Access Scheme. You can learn more about the Curaleaf Access Scheme here.

We would like to extend thanks to all who are signed up to the Curaleaf Access Scheme without whom this research would not be possible.

Share this article
X
Facebook
WhatsApp
LinkedIn
Email

Am I eligible?

We aim to make things easy and to keep you informed of your progress every step of the way, from the moment you apply to the receipt of your prescription(s).
Related Articles
Blog, News
08/07/2025

It’s natural to have questions when considering a new medication, and for many exploring medical cannabis, a common ...

Read more
News
04/07/2025

Living with chronic pain can be challenging, and finding effective treatments is a priority for many. Chronic pain, ...

Read more
News
25/06/2025

At Curaleaf Clinic, we care for thousands of patients living with long-term pain. Many share how challenging it ...

Read more